Skip to content

Month: February 2012

Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa Condition:   Retinitis PigmentosaIntervention:   Other: BM-MSCSponsors:   Mahidol University;   Ministry of Health, ThailandEnrolling by invitation – verified August 2017 Source: ClinicalTrials.gov – Retinitis Pigmentosa – Feasibility and Safety…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest